Home › Free Stock Grades › IRTC
iRhythm Technologies, Inc. (IRTC) Stock Grade
IRTC · Healthcare
A+
Market Cap
$5.7B
P/E Ratio
—
Revenue Growth (YoY)
+26.2%
Net Margin
-6.0%
Return on Equity
—
Dividend Yield
None
About iRhythm Technologies, Inc.'s fundamentals
iRhythm Technologies is a medical device company with a market capitalization of $5.7 billion that is growing revenue rapidly at 26.2% year-over-year. Despite strong revenue growth, the company is currently unprofitable with a net margin of -6.0% and reported a net loss in its latest annual statement. However, the company is generating positive free cash flow despite its accounting losses, indicating that its core operations are producing cash despite not yet reaching profitability. The company does not pay a dividend.